A PROSPECTIVE, OBSERVATIONAL, MULTICENTRE, 2 YEAR STUDY EVALUATING THE USE OF EYLEA (AFLIBERCEPT) FOR THE TREATMENT OF NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION IN UK NHS OPTHALMOLOGY CLINICS: